By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Isis Pharmaceuticals, Inc. 

Carlsbad Research Center
2292 Faraday Avenue
Carlsbad  California  92008-7208  U.S.A.
Phone: 760-931-9200 Fax: 760-603-4650



Company News
Isis Pharma (ISIS) Mulls Name Change After Paris Attacks 11/17/2015 7:44:06 AM
Isis Pharma (ISIS) Earns $2.8m For Advancing Isis-Dmpk-2.5 Rx In Patients With Myotonic Dystrophy Type I 11/10/2015 6:24:50 AM
Isis Pharma (ISIS) Reports Financial Results And Highlights For Third Quarter 2015 11/9/2015 10:34:34 AM
Isis Pharma (ISIS) Reports Positive Clinical Data From Lp(a) Lowering Drugs 11/9/2015 6:59:23 AM
Isis Pharma (ISIS) To Present At Upcoming Investor Conferences 11/6/2015 9:43:20 AM
Isis Pharma (ISIS) And Akcea Therapeutics Announce Start Of Phase 3 Study Of Volanesorsen In Patients With Familial Partial Lipodystrophy 11/5/2015 6:13:04 AM
Isis Pharma (ISIS) To Host Webcast To Review ISIS-APO(A) Rx And ISIS-APO(A)-L Rx Data Presented At American Heart Association Scientific Sessions 11/4/2015 7:18:45 AM
Isis Pharma (ISIS) Reports An Update On ISIS-TTR Rx, Including Positive Data From Multiple Clinical Studies, Presented Today At The EC-ATTR Meeting 11/3/2015 6:24:23 AM
Isis Pharma (ISIS) Initiates Phase 2 Study Of ISIS-FXI Rx In Patients With End-Stage Renal Disease On Hemodialysis 10/30/2015 6:20:07 AM
Isis Pharma (ISIS) To Host Webcast To Review ISIS-TTR Rx Data Presented At 1st European Congress Of Hereditary ATTR Amyloidosis And Provide Phase 3 Development Plan Update 10/27/2015 11:58:48 AM